Richard W. Paul & Associates, LLC Aquestive Therapeutics, Inc. Transaction History
Richard W. Paul & Associates, LLC
- $251 Billion
- Q1 2024
A detailed history of Richard W. Paul & Associates, LLC transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Richard W. Paul & Associates, LLC holds 1,472 shares of AQST stock, worth $3,532. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,472
Previous 1,423
3.44%
Holding current value
$3,532
Previous $2.88 Million
118.05%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding AQST
# of Institutions
105Shares Held
42.1MCall Options Held
463KPut Options Held
431K-
Bratton Capital Management, L.P. Fort Worth, TX9.81MShares$23.5 Million100.0% of portfolio
-
Vr Adviser, LLC New York, NY5.56MShares$13.3 Million2.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.24MShares$7.78 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA2.22MShares$5.33 Million0.0% of portfolio
-
Laurion Capital Management LP New York, NY1.55MShares$3.71 Million0.06% of portfolio
About Aquestive Therapeutics, Inc.
- Ticker AQST
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,350,700
- Market Cap $128M
- Description
- Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...